Digital health technologies are rapidly innovating the healthcare model in wearables, telehealth platforms, AI-driven diagnostics, and digital therapeutics. Properly harnessed, such digital assets hold immense potential to greatly change patient care, and improve outcomes, with considerable opportunities to effectively reduce cost of treatment. Nevertheless, the journey from the conceptualization of these technologies to their real-world application is not that easy and is generally found littered with challenges. A crucial factor in the successful adoption of these innovations is the development of robust market access frameworks that clearly illustrate the advantages these technologies can bring to patient care. These technologies offer immense benefits to the end users, helping the process of adoption, and also ensuring that the correct treatment is delivered to the patients in need, at the right time and cost. By establishing these frameworks, it is possible to seamlessly integrate digital health assets into mainstream healthcare, and transform the industry forever.[1,2]

Billions of dollars are invested worldwide in medical product development, including digital health assets, increasing the pressure to maximize the revenues of these investments. A market access decision clearly assumes a thorough understanding of decision-making in various health systems. The market access for digital health technologies implies overcoming regulatory requirements, securing reimbursement, and attaining widespread acceptance among healthcare providers and patients.[3,4]

Regulatory authorities such as the FDA in the United States and the EMA in Europe are essential in safeguarding the safety, effectiveness, and dependability of digital health products. For example, the FDA’s Digital Health Innovation Action Plan outlines a comprehensive roadmap for developers, highlighting the importance of substantial clinical evidence and ongoing post-market surveillance. Understanding and complying with these regulations not only facilitates quicker market access but also fosters confidence among healthcare providers and patients.[5]

Reimbursement models are essential for maintaining the financial sustainability of digital health technologies. They determine the payment mechanisms for these services and products, which may include insurance coverage, government initiatives, or direct payments from patients. Generally, government bodies and regulatory agencies have a big influence in the formation of key healthcare policies and in shaping of pricing and reimbursement structures in many countries.[6] For instance, they may introduce financing assistance initiatives, such as the Medical Devices program that provides regulatory and financial support to companies, or the breakthrough devices program aimed at improving access to medical devices for treating life-threatening or debilitating conditions. Additionally, insurance companies also have a significant role, albeit with limitations that can pose financial barriers for patients with insurance covers.[7]

In light of these challenges, it is paramount to develop open and sustainable concepts of reimbursement to allow for broad acceptance of digital health technologies. Their integration into existing insurance models could provide a powerful incentive for healthcare providers to implement these innovations and enhance patient care.[7]

A market entry strategy for digital health technologies needs to engage key stakeholders at the healthcare provider, patient, payer, and policymaker levels. This engagement allows for the resolution of concerns and gathering of valuable feedback. Engaging clinicians, for instance, could ensure that the technology is developed in a way that meets their requirements and is fully integrated into their workflows. When patients are engaged the tool would further enhance usability and acceptance of digital health, ensuring they are user-friendly and addressing real patient needs.[8]

A 2021 study corroborates this approach by showing that all stakeholder groups, including venture capitalists, digital health companies, payers, and providers – firmly believed that the engagement of frontline providers and patients was one of the main driving forces for the widespread diffusion of patient-facing digital tools. Here, one can see just how the power of collaborative efforts and deliverance of engagement work together in surmounting barriers to adoption and hence in creating an enabling environment for digital health innovations.[9]

The future of market access for digital health assets depends on the adoption of innovations while continuing to be flexible in regulatory and reimbursement frameworks. In keeping with constant evolution in digital health technologies, the frameworks have to morph and adapt with new developments that come up. It may involve creation of agile regulatory procedures that provide fast-track access to low-risk digital health products or innovative reimbursement models that represent the unique value propositions of digital health solutions. Moreover, strong data privacy and security will be important in maintaining the information of patients for building user confidence, hence facilitating the broader diffusion of these technologies. The full potential of digital health assets can only be potentially unlocked if regulatory agility and data protection are addressed, therefore taking a step to further improve healthcare outcomes.[10]

In summary, gaining market access to digital health assets requires a multifaceted strategy that necessitates the establishment of comprehensive frameworks. These frameworks must encompass regulatory compliance, reimbursement structures, stakeholder engagement, and the capacity for innovation and flexibility. The development of such frameworks shall aid in fully tapping into the potentials of these digital assets for transforming the healthcare landscape towards better health outcomes for all. Collaboration between stakeholders and a commitment to adapt to new advancements will be key to successfully traversing this evolving field.potential

Become A Certified HEOR Professional – Enrol yourself here!

References

1. Fraser AG, Nelissen RG, Kjærsgaard-Andersen P, Szymański P, Melvin T, Piscoi P. Improved clinical investigation and evaluation of high-risk medical devices: the rationale and objectives of CORE–MD (Coordinating Research and Evidence for Medical Devices). EFORT open reviews. 2021 Oct 19;6(10):839-49.
2. Farah L, Borget I, Martelli N. International Market Access Strategies for Artificial Intelligence–Based Medical Devices: Can We Standardize the Process to Faster Patient Access?. Mayo Clinic Proceedings: Digital Health. 2023 Sep 1;1(3):406-12.
3. Dorsey ER, De Roulet J, Thompson JP, Reminick JI, Thai A, W et al. Funding of US biomedical research, 2003-2008. Jama. 2010 Jan 13;303(2):137-43.
4. Ijzerman MJ, Steuten LM. Early assessment of medical technologies to inform product development and market access: a review of methods and applications. Applied health economics and health policy. 2011 Sep;9:331-47.
5. FDA. Digital Health Innovation Action Plan. Retrieved from https://www.fda.gov/media/106331/download
6. Chinyio E, Olomolaiye P, editors. Construction stakeholder management. John Wiley & Sons; 2009 Oct 22.
7. Woo JH, Kim EC, Kim SM. The current status of breakthrough devices designation in the United States and innovative medical devices designation in Korea for digital health software. Expert Review of Medical Devices. 2022 Mar 4;19(3):213-28.
8. Vat LE, Finlay T, Robinson P, Barbareschi G, Boudes M, et al. Evaluation of patient engagement in medicine development: A multi‐stakeholder framework with metrics. Health Expectations. 2021 Apr;24(2):491-506.
9. Lyles CR, Adler-Milstein J, Thao C, Lisker S, Nouri S, Sarkar U. Alignment of key stakeholders’ priorities for patient-facing tools in digital health: mixed methods study. Journal of Medical Internet Research. 2021 Aug 26;23(8):e24890.
10. Rockwern B, Johnson D, Snyder Sulmasy L, Medical Informatics Committee and Ethics, Professionalism and Human Rights Committee of the American College of Physicians. Health information privacy, protection, and use in the expanding digital health ecosystem: a position paper of the American College of Physicians. Annals of Internal Medicine. 2021 Jul;174(7):994-8.